Chest
Volume 156, Issue 5, November 2019, Pages 864-877
Journal home page for Chest

Original Research: COPD
Effects of Clinical Pathways for COPD on Patient, Professional, and Systems Outcomes: A Systematic Review

Part of this article has been presented earlier (Plishka C, Rotter T, Kinsman L, et al. Systematic Rev. 2016;5:135).
https://doi.org/10.1016/j.chest.2019.04.131Get rights and content

Background

COPD has a substantial burden seen in both patient quality of life and health-care costs. One method of minimizing this burden is the implementation of clinical pathways (CPWs). CPWs bring the best available evidence to a range of health-care professionals by adapting guidelines to a local context and detailing essential steps in care.

Methods

A systematic review was conducted to address the following question: What are the effects of CPWs for COPD on patient-, professional-, and systems-level outcomes? The review used methods outlined by the Cochrane Collaboration. We included all studies that met our operational definition for CPWs and focused on COPD. All studies were evaluated for risk of bias, and all data regarding patient, professional, and systems outcomes were extracted.

Results

The search strategy identified 497 potentially relevant titles. Of these, 13 studies were included in the review. These studies reported a total of 398 outcomes, with sufficient data for meta-analysis of five outcomes: complications, length of stay, mortality, readmissions, and quality of life. Results showed statistically significant reductions in complications, readmissions, and length of stay but did not show changes in mortality or quality of life.

Conclusions

This systematic review reveals evidence to suggest that CPWs for COPD have the potential to reduce complications, readmissions, and length of stay without negatively influencing mortality or quality of life. However, quality of evidence was generally low. The authors therefore acknowledge that results should be interpreted with caution and note the need for additional research in this area.

Section snippets

Description of the Condition

COPD is a respiratory disease characterized by progressive, partially reversible airway obstruction and lung hyperinflation.1, 2 This leads to progressive shortness of breath, limitation of daily activities, worsening health-related quality of life, and increasingly frequent and severe exacerbations.1 The disease is significantly underdiagnosed,3, 4 leading to difficulty in estimating prevalence at both the international and national levels. Estimates for worldwide prevalence of COPD range from

Materials and Methods

The current review follows the methodology outlined in a previously published review protocol.32 Methods are based on the guidelines provided by the Cochrane Collaboration.33 For brevity, this section only outlines the authors who completed each task and notes changes from the protocol.32 Due to the nature of this research, ethics approval was not required.

Screening

The search regarding CPWs in primary care resulted in 312 potentially relevant search hits, and the search regarding CPWs in hospitals resulted in 257 potentially relevant search hits. Hand-searching identified an additional six potentially relevant articles. Together, this approach resulted in a total of 575 search hits. Of these, 78 were duplicates, leaving 497 potentially relevant hits.

All search hits were screened independently by two reviewers (C. T. P. and Adegboyega Lawal, MPH).

Discussion

An overview of findings along with the justification for quality of evidence ratings is presented in Table 3. These findings suggest that CPWs for COPD have the potential to reduce complications (very low quality of evidence), reduce readmissions (high quality of evidence), and reduce length of stay (low quality of evidence). Furthermore, they did not point toward changes in mortality (low quality of evidence) or quality of life (low quality of evidence).

Conclusions

The current systematic review objectively found a number of benefits resulting from the implementation of CPWs for COPD. The results reveal high-quality evidence suggesting that CPWs for COPD have the potential to reduce readmissions. In addition, there is low-quality evidence to suggest that CPWs may reduce complications and length of stay regarding COPD. Finally, the evidence does not point to positive or negative changes to mortality rate or patient quality of life. Although these findings

Acknowledgments

Author contributions: D. D. M. and T. R. act as the guarantor of this research and take responsibility for the integrity of the work as a whole, from inception to published article. C. T. P., D. D. M., E. D. P., and T. R. made substantial contributions to conception and design. C. T. P., D. D. M., T. R., and S.-K. A. F. made substantial contributions to the acquisition of data. C. T. P., D. D. M., E. D. P., M. R. H., and T. R. made substantial contributions to analysis and interpretation of

References (65)

  • D.E. O'Donnell et al.

    Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease—2008 update—highlights for primary care

    Can Respir J

    (2008)
  • Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: 2018 report

  • Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach

  • J. Evans et al.

    Estimating the prevalence of COPD in Canada: Reported diagnosis versus measured airflow obstruction

  • Chronic obstructive pulmonary disease (COPD)

  • Centers for Disease Control and Prevention, National Center for Health Statistics

    National Hospital Discharge Survey Raw Data, 1999-2010: Analysis Performed by the American Lung Association Research and Health Education Division Using SPSS Software

    (2010)
  • Confronting COPD in America: Executive Summary

    (2001)
  • N. Mittmann et al.

    The cost of moderate and severe COPD exacerbations to the Canadian healthcare system

    Respir Med

    (2008)
  • G.J. Criner et al.

    Executive summary: prevention of acute exacerbation of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline

    Chest

    (2015)
  • J.M. Grimshaw et al.

    Disseminating and implementing guidelines: article 13 in integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report

    Proc Am Thorac Soc

    (2012)
  • D.D. Marciniuk et al.

    Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: a Canadian Thoracic Society clinical practice guideline

    Can Respir J

    (2011)
  • A. Qaseem et al.

    Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society

    Ann Intern Med

    (2011)
  • D.E. O'Donnell et al.

    Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease—2003

    Can Respir J

    (2003)
  • J. Bourbeau et al.

    CTS position statement: pharmacotherapy in patients with COPD—an update

    Can J Respir Critical Care Sleep Med

    (2017)
  • D.D. Marciniuk et al.

    Optimizing pulmonary rehabilitation in chronic obstructive pulmonary disease—practical issues: a Canadian Thoracic Society Clinical Practice Guideline

    Can Respir J

    (2010)
  • Saskatoon Health Region Annual report 2008/2009

  • L.A. Bero et al.

    Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. The Cochrane Effective Practice and Organization of Care Review Group

    Br Med J

    (1998)
  • J.M. Grimshaw et al.

    Changing provider behavior: an overview of systematic reviews of interventions

    Medical Care

    (2001)
  • J.M. Grimshaw et al.

    Effectiveness and efficiency of guideline dissemination and implementation strategies

    Health Technol Assess

    (2004)
  • J. Grimshaw et al.

    Implementing clinical guidelines: current evidence and future implications

    J Continuing Educ Health Professions

    (2004)
  • E.A. McGlynn et al.

    The quality of health care delivered to adults in the United States

    N Engl J Med

    (2003)
  • R. Grol

    Successes and failures in the implementation of evidence-based guidelines for clinical practice

    Medical Care

    (2001)
  • J.M. Westfall et al.

    Practice-based research—"Blue Highways" on the NIH roadmap

    JAMA

    (2007)
  • H. Campbell et al.

    Integrated care pathways

    Br Med J

    (1998)
  • L. Kinsman et al.

    What is a clinical pathway? Development of a definition to inform the debate

    BMC Medicine

    (2010)
  • T. Rotter et al.

    Clinical pathways: effects on professional practice, patient outcomes, length of stay and hospital costs

    Cochrane Database Syst Rev

    (2010)
  • T. Rotter et al.

    Clinical pathways for primary care: effects on professional practice, patient outcomes, and costs

    Cochrane Database Syst Rev

    (2013)
  • S. Cunningham et al.

    Effect of an integrated care pathway on acute asthma/wheeze in children attending hospital: cluster randomized trial

    J Pediatr

    (2008)
  • T. Rotter et al.

    A systematic review and meta-analysis of the effects of clinical pathways on length of stay, hospital costs and patient outcomes

    BMC Health Serv Res

    (2008)
  • G. Schrijvers et al.

    The care pathway: concepts and theories: an introduction

    Int J Integrated Care

    (2012)
  • C. Lodewijckx et al.

    Impact of care pathways for in-hospital management of COPD exacerbation: a systematic review

    Int J Nursing Studies

    (2011)
  • C. Plishka et al.

    Effects of clinical pathways for chronic obstructive pulmonary disease (COPD) on patient, professional and systems outcomes: protocol for a systematic review

    Systematic Reviews

    (2016)
  • Cited by (0)

    FUNDING/SUPPORT: The protocol and systematic review have been supported by the Lung Health Institute of Canada.

    Collaborators from the Saskatchewan COPD CPWs Research Group are listed in the Acknowledgments.

    View full text